Open original FDA record ↗Recall record
- FDA identifier
- Z-1091-2022
- Company in FDA record
- Neuralynx Inc
- FDA record creation date
- May 13, 2022
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Atlas Stim Headbox (ASHB) was delivered to US customers under a premise that the device had an Investigational Device Exemption (IDE) and was for research use only, but the manufacturer does not have an approved IDE by the FDA. The product has not undergone electrical safety testing and has not received regulatory clearance.
Source facts
- Action
- Customer notifications were sent out to all affected customers on March 14, 2022, via USPS certified mail. Actions to be taken: Field representatives will be contacting consignees to return the effected product and coordinate a replacement with their cleared headbox, product models 31-0601-0007, 31-0601-0010 or 31-0601-0017, by April 6, 2022. In the interim, it is advised to stop use of this product. Any further questions regarding this matter, contact by email at kmoeykens@fh-co.com or by telephone at 207-666-5425 Monday -Friday 8:00 AM -4:30 PM EST.
- Initiated
- 2022-03-14
- Root cause
- No Marketing Application
- Distribution
- U.S. Nationwide distribution in the states of AL, CA, IL, MN, NC, RI.
- Recall number
- Z-1091-2022
- Recall status
- Open, Classified
- CDRH record ID
- 192671
- FDA record created
- 2022-05-13
- Recall event number
- 89843